Evidence for an association between tumor necrosis factor-alpha levels and lithium response
Authors:
- Sinan GuloksuzSGSinan Guloksuz
- Kursat AltinbasKAKursat Altinbas
- Esin Aktas CetinECEsin Aktas Cetin
- Gunter KenisGKGunter Kenis
- Sema Bilgic GaziogluSGSema Bilgic Gazioglu
- Gunnur DenizGDGunnur Deniz
- E. Timucin OralEOE. Timucin Oral
- Jim van OsJOJim van Os
- 1 December 2012
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 143 (1-3) , 148-152
Abstract
No abstract availableKeywords
Funding Information
- Seventh Framework Programme (HEALTH-F2-2009-241909)
This publication has 20 references indexed in Scilit:
- Peripheral biomarkers and illness activity in bipolar disorderJournal of Psychiatric Research, 2011
- Cytokine levels in euthymic bipolar patientsJournal of Affective Disorders, 2010
- The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium TreatmentNeuropsychobiology, 2010
- The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression?NeuroToxicology, 2009
- Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled studyHuman Psychopharmacology: Clinical and Experimental, 2008
- An imbalance in the production of IL‐1β and IL‐6 by monocytes of bipolar patients: restoration by lithium treatmentBipolar Disorders, 2007
- Immune variations in bipolar disorder: phasic differencesBipolar Disorders, 2007
- Cytokine production in bipolar affective disorder patients under lithium treatmentJournal of Affective Disorders, 2004
- Immune parameters in rapid cycling bipolar patients before and after lithium treatmentJournal of Psychiatric Research, 1999
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999